Title: Dual mTOR inhibitor MLN0128 suppresses Merkel cell carcinoma (MCC) xenograft tumor growth.
Journal: Oncotarget 20160209
Title: Dual mTORC1/2 and HER2 blockade results in antitumor activity in preclinical models of breast cancer resistant to anti-HER2 therapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20120501
Title: The translational landscape of mTOR signalling steers cancer initiation and metastasis.
Journal: Nature 20120222
Title: ATP-competitive inhibitors of mTOR: an update.
Journal: Current medicinal chemistry 20110101
Title: mTOR Mediated Anti-Cancer Drug Discovery.
Journal: Drug discovery today. Therapeutic strategies 20090101
Title: Liu A, et al. mTOR Mediated Anti-Cancer Drug Discovery. Drug Discovery Today: Therapeutic Strategies. 2009, 6(2), 47-55.
Title: Hsieh AC, et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature. 2012 Feb 22;485(7396):55-61.
